ANAB · Anaptysbio, Inc
$53.76
+3.47 (+6.90%)
At close · Jul 21
Market Cap
$1.56B
Shares
29.10M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| DEF 14A | 2026-06-29 | — | |
| 8-K | 2026-06-22 | 2026-06-15 | |
| 8-K | 2026-05-29 | — | |
| 8-K | 2026-05-21 | 2026-05-18 | |
| 8-K | 2026-05-12 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| 8-K | 2026-05-11 | — | |
| 10-K/A | 2026-04-28 | 2025-12-31 | |
| 8-K/A | 2026-04-24 | 2026-04-20 | |
| 8-K | 2026-04-20 | — | |
| Investor Event Transcript | 2026-03-31 | — | |
| 8-K | 2026-03-27 | 2026-03-26 | |
| 10-K | 2026-03-03 | 2025-12-31 | |
| 8-K | 2026-03-03 | — | |
| 8-K | 2026-01-09 | — | |
| 8-K | 2025-11-26 | — | |
| 8-K | 2025-11-21 | — | |
| 8-K | 2025-11-21 | 2025-11-20 | |
| 8-K | 2025-11-10 | — | |
| 10-Q | 2025-11-04 | 2025-09-30 | |
| 8-K | 2025-11-04 | — | |
| 8-K | 2025-10-14 | — | |
| Investor Event Transcript | 2025-09-30 | — | |
| 8-K | 2025-09-29 | — | |
| 8-K | 2025-08-06 | — | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-06-17 | — | |
| 8-K | 2025-06-03 | — | |
| 8-K | 2025-05-05 | — | |
| 10-Q | 2025-05-05 | 2025-03-31 | |
| DEF 14A | 2025-04-29 | 2025-06-17 | |
| 8-K | 2025-03-24 | — | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-27 | — | |
| 8-K | 2025-02-19 | — | |
| 8-K | 2025-02-12 | — | |
| 8-K | 2025-02-03 | 2025-01-31 | |
| 8-K | 2024-12-11 | — | |
| 10-Q | 2024-11-05 | 2024-09-30 | |
| 8-K | 2024-11-05 | — | |
| 8-K | 2024-08-14 | 2024-08-13 | |
| 8-K | 2024-08-05 | — | |
| 10-Q | 2024-08-05 | 2024-06-30 | |
| 8-K | 2024-06-12 | — | |
| 10-Q | 2024-05-09 | 2024-03-31 | |
| 8-K | 2024-05-09 | — | |
| DEF 14A | 2024-04-24 | 2024-06-12 | |
| 10-K | 2024-03-11 | 2023-12-31 | |
| 8-K | 2024-03-11 | — | |
| 8-K | 2024-01-05 | — |
Showing 1–50 of 122 filings
Key facts
CIK
1370053
CUSIP
032724106
13F (30d)
16 filings
15 filers
Visit website
Investor relations